Caption Management, LLC - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 172 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
Caption Management, LLC ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,767,580
+48.3%
757,000
+308.7%
0.10%
+67.7%
Q3 2022$4,563,000
+488.8%
185,200
+640.8%
0.06%
+588.9%
Q4 2021$775,000
-78.7%
25,000
-83.3%
0.01%
-78.6%
Q3 2021$3,638,000
+94.2%
150,000
+16.8%
0.04%
+75.0%
Q2 2021$1,873,000128,4000.02%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,084,300$15,820,0003.32%
ARMISTICE CAPITAL, LLC 5,748,000$83,863,0001.50%
RA Capital Management 5,614,428$81,915,0001.32%
Krensavage Asset Management, LLC 140,000$2,043,0000.69%
CM Management, LLC 60,000$875,0000.63%
Altium Capital Management LP 170,484$2,487,0000.58%
HighVista Strategies LLC 53,498$781,0000.55%
Sio Capital Management, LLC 150,000$2,189,0000.54%
MANGROVE PARTNERS IM, LLC 295,037$4,305,0000.44%
Rock Springs Capital Management LP 1,494,164$21,800,0000.43%
View complete list of TRAVERE THERAPEUTICS INC shareholders